Johnson & Johnson MedTech Announces Strategic Agreement with Responsive Arthroscopy to Expand Sports Soft Tissue Solutions

November 14, 2024 – Johnson & Johnson MedTech, a global leader in orthopaedic technologies, has entered an exclusive commercial distribution agreement in the U.S. with Responsive Arthroscopy Inc., a company specializing in sports soft tissue repair solutions. This partnership strengthens Johnson & Johnson MedTech’s presence in the rapidly expanding sports soft tissue repair market by enhancing its product portfolio to meet growing demand.

Aldo Denti, Company Group Chairman, Orthopaedics, Johnson & Johnson MedTech, emphasized the strategic importance of this collaboration, stating, “This relationship with Responsive Arthroscopy is a significant step in expanding our leadership in orthopaedics and advancing our sports soft tissue offerings. It enables us to deliver a broader range of cutting-edge tools for surgeons in shoulder, foot, and ankle procedures, driving value in this growing segment while advancing patient care.” The agreement combines Johnson & Johnson MedTech’s expertise in orthopaedic innovation with Responsive Arthroscopy’s advanced technologies, providing healthcare providers with a more comprehensive toolset for evolving clinical needs. This collaboration underscores Johnson & Johnson MedTech’s commitment to delivering impactful solutions that improve orthopaedic outcomes and elevate patient care. As part of its mission, Johnson & Johnson MedTech leverages its expertise across joint reconstruction, robotics, spine, sports medicine, and trauma to create next-generation medical technologies.

With one of the most comprehensive orthopaedics portfolios globally, Johnson & Johnson MedTech aims to restore movement and improve the quality of life for millions of patients. This partnership with Responsive Arthroscopy represents another step forward in its vision to address complex health challenges and innovate in orthopaedic care.